The DOI matches its Crossref record; 29 of the 30 references it cites were found in a registry or an index.
Thermal profiling reveals phenylalanine hydroxylase as an off-target of panobinostat
Open accessAbstract
We describe a two-dimensional thermal proteome profiling strategy that can be combined with an orthogonal chemoproteomics approach to enable comprehensive target profiling of the marketed histone deacetylase inhibitor panobinostat. The N-hydroxycinnamide moiety is identified as critical for potent and tetrahydrobiopterin-competitive inhibition of phenylalanine hydroxylase leading to increases in phenylalanine and decreases in tyrosine levels. These findings provide a rationale for adverse clinical observations and suggest repurposing of the drug for treatment of tyrosinemia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Consider TTC38, for instance, a poorly characterized protein that has been previously identified as an off-target of the HDAC inhibitor panobinostat36 and found herein to display stereoselective interaction with the (S)-4 probe that was blocked by panobinostat.”
From Expedited mapping of the ligandable proteome using fully functionalized enantiomeric probe pairs (2019) · cites this paper as [36]
Citations
Cites
Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
Molina, D. M., Jafari, R., Ignatushchenko, M., Seki, T., Larsson, E. A., Dan, C., Sreekumar, L., Cao, Y., & Nordlund, P. (2013) · Science · doi:10.1126/science.1233606 · Cited by 2,261
A Human Protein Atlas for Normal and Cancer Tissues Based on Antibody Proteomics
Uhlén, M., Björling, E., Agaton, C., Szigyarto, C. A., Amini, B., Andersen, E., Andersson, A., Angelidou, P., Asplund, A., Asplund, C., et al. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500279-mcp200 · Cited by 1,560
Tracking cancer drugs in living cells by thermal profiling of the proteome
Savitski, M. M., Reinhard, F. B. M., Franken, H., Werner, T., Savitski, M. F., Eberhard, D., Molina, D. M., Jafari, R., Dovega, R. B., Klaeger, S., et al. (2014) · Science · doi:10.1126/science.1255784 · Cited by 1,187
Self-citationTarget identification and mechanism of action in chemical biology and drug discovery
Schenone, M., Dančík, V., Wagner, B. K., & Clemons, P. A. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1199 · Cited by 1,147
Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes
Bantscheff, M., Hopf, C., Savitski, M. M., Dittmann, A., Grandi, P., Michon, A.-M., Schlegl, J., Abraham, Y., Becher, I., Bergamini, G., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1759 · Cited by 659
Self-citationFranken, H., Mathieson, T., Childs, D., Sweetman, G. M. A., Werner, T., Tögel, I., Doce, C., Gade, S., Bantscheff, M., Drewes, G., et al. (2015) · Nature Protocols · doi:10.1038/nprot.2015.101 · Cited by 651
Self-citationTarget Identification for Small Bioactive Molecules: Finding the Needle in the Haystack
Ziegler, S., Pries, V., Hedberg, C., & Waldmann, H. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201208749 · Cited by 473
Development of the pan-DAC inhibitor panobinostat (LBH589): Successes and challenges
Atadja, P. W. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.02.019 · Cited by 427
Thermal proteome profiling monitors ligand interactions with cellular membrane proteins
Reinhard, F. B. M., Eberhard, D., Werner, T., Franken, H., Childs, D., Doce, C., Savitski, M. F., Huber, W. K., Bantscheff, M., Savitski, M. M., et al. (2015) · Nature Methods · doi:10.1038/nmeth.3652 · Cited by 310
Self-citationMolina, D. M., & Nordlund, P. (2015) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010715-103715 · Cited by 301
Flagged first, then by citations
1 of the 30 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Bailey, H., Stenehjem, D.D. & Sharma, S. J. Blood Med. 6, 269–276 (2015).
Cited by
Sorted by citations
Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery
Thomford, N. E., Senthebane, D. A., Rowe, A., Munro, D., Seele, P. P., Maroyi, A., & Dzobo, K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061578 · Cited by 1,301
A deep proteome and transcriptome abundance atlas of 29 healthy human tissues
Wang, D., Eraslan, B., Wieland, T., Hallström, B., Hopf, T., Zolg, D. P., Zecha, J., Asplund, A., Li, L., Meng, C., et al. (2019) · Molecular Systems Biology · doi:10.15252/msb.20188503 · Cited by 750
A new antibiotic selectively kills Gram-negative pathogens
Imai, Y., Meyer, K. J., Iinishi, A., Favre-Godal, Q., Green, R., Manuse, S., Caboni, M., Mori, M., Niles, S., Ghiglieri, M., et al. (2019) · Nature · doi:10.1038/s41586-019-1791-1 · Cited by 757
Self-citationLi, J., Vranken, J. G. V., Vaites, L. P., Schweppe, D. K., Huttlin, E. L., Etienne, C. L., Nandhikonda, P., Viner, R., Robitaille, A. M., Thompson, A. H., et al. (2020) · Nature Methods · doi:10.1038/s41592-020-0781-4 · Cited by 440
Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation
Gilan, O., Rioja, I., Knezevic, K., Bell, M. J., Yeung, M. M., Harker, N., Lam, E. Y. N., Chung, C., Bamborough, P., Petretich, M., et al. (2020) · Science · doi:10.1126/science.aaz8455 · Cited by 453
Self-citationA Dual-Mechanism Antibiotic Kills Gram-Negative Bacteria and Avoids Drug Resistance
Martin, J. K., Sheehan, J. P., Bratton, B. P., Moore, G. M., Mateus, A., Li, H., Kim, H., Rabinowitz, J. D., Typas, A., Savitski, M. M., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.005 · Cited by 358
Self-citationThe emerging role of mass spectrometry-based proteomics in drug discovery
Meissner, F., Geddes‐McAlister, J., Mann, M., & Bantscheff, M. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00409-3 · Cited by 373
Self-citationBioaccumulation of therapeutic drugs by human gut bacteria
Klünemann, M., Andrejev, S., Blasche, S., Mateus, A., Phapale, P. B., Devendran, S., Vappiani, J., Simon, B., Scott, T. A., Kafkia, E., et al. (2021) · Nature · doi:10.1038/s41586-021-03891-8 · Cited by 347
Self-citationProteome Integral Solubility Alteration: A High-Throughput Proteomics Assay for Target Deconvolution
Gaetani, M., Sabatier, P., Saei, A. A., Beusch, C. M., Yang, Z., Lundström, S. L., & Zubarev, R. A. (2019) · Journal of Proteome Research · doi:10.1021/acs.jproteome.9b00500 · Cited by 287
Meltome atlas—thermal proteome stability across the tree of life
Jarząb, A., Kurzawa, N., Hopf, T. A., Moerch, M., Zecha, J., Leijten, N. M., Bian, Y., Musiol, E., Maschberger, M., Stoehr, G., et al. (2020) · Nature Methods · doi:10.1038/s41592-020-0801-4 · Cited by 285
Self-citationThermal proteome profiling for interrogating protein interactions
Mateus, A., Kurzawa, N., Becher, I., Sridharan, S., Helm, D., Stein, F., Typas, A., & Savitski, M. M. (2020) · Molecular Systems Biology · doi:10.15252/msb.20199232 · Cited by 258
Self-citationProteome-wide solubility and thermal stability profiling reveals distinct regulatory roles for ATP
Sridharan, S., Kurzawa, N., Werner, T., Günthner, I., Helm, D., Huber, W. K., Bantscheff, M., & Savitski, M. M. (2019) · Nature Communications · doi:10.1038/s41467-019-09107-y · Cited by 270
Self-citationThe evolving role of investigative toxicology in the pharmaceutical industry
Pognan, F., Beilmann, M., Boonen, H. C. M., Czich, A., Dear, G. J., Hewitt, P. G., Mow, T. J., Oinonen, T., Roth, A. B., Steger‐Hartmann, T., et al. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00633-x · Cited by 280
Pervasive Protein Thermal Stability Variation during the Cell Cycle
Becher, I., Andrés‐Pons, A., Romanov, N., Stein, F., Schramm, M., Baudin, F., Helm, D., Kurzawa, N., Mateus, A., Mackmull, M., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.053 · Cited by 225
Self-citationExtended pharmacodynamic responses observed upon PROTAC-mediated degradation of RIPK2
Mares, A., Miah, A. H., Smith, I. E. D., Rackham, M., Thawani, A. R., Cryan, J., Haile, P. A., Votta, B. J., Beal, A. M., Capriotti, C., et al. (2020) · Communications Biology · doi:10.1038/s42003-020-0868-6 · Cited by 232
Self-citationMultiplexed Proteome Dynamics Profiling Reveals Mechanisms Controlling Protein Homeostasis
Savitski, M. M., Zinn, N., Faelth-Savitski, M., Poeckel, D., Gade, S., Becher, I., Muelbaier, M., Wagner, A. J., Strohmer, K., Werner, T., et al. (2018) · Cell · doi:10.1016/j.cell.2018.02.030 · Cited by 217
Self-citationTu, Y., Tan, L., Tao, H., Li, Y., & Liu, H. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154862 · Cited by 201
Thermal proteome profiling in bacteria: probing protein state in vivo
Mateus, A., Bobonis, J., Kurzawa, N., Stein, F., Helm, D., Hevler, J. F., Typas, A., & Savitski, M. M. (2018) · Molecular Systems Biology · doi:10.15252/msb.20188242 · Cited by 192
Self-citationPiazza, I., Beaton, N., Bruderer, R., Knobloch, T., Barbisan, C., Chandat, L., Sudau, A., Siepe, I., Rinner, O., de Souza, N., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18071-x · Cited by 192
Expedited mapping of the ligandable proteome using fully functionalized enantiomeric probe pairs
Wang, Y., Dix, M. M., Bianco, G., Remsberg, J. R., Lee, H.-Y., Kalocsay, M., Gygi, S. P., Forli, S., Vite, G., Lawrence, R. M., et al. (2019) · Nature Chemistry · doi:10.1038/s41557-019-0351-5 · Cited by 179
Identifying drug targets in tissues and whole blood with thermal-shift profiling
Perrin, J., Werner, T., Kurzawa, N., Rutkowska, A., Childs, D. D., Kalxdorf, M., Poeckel, D., Stonehouse, E., Strohmer, K., Heller, B., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-019-0388-4 · Cited by 178
Self-citationThinking Outside the Box—Novel Antibacterials To Tackle the Resistance Crisis
Lakemeyer, M., Zhao, W., Mandl, F. A. M., Hammann, P., & Sieber, S. A. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201804971 · Cited by 173
Mateus, A., Määttä, T. A., & Savitski, M. M. (2016) · Proteome Science · doi:10.1186/s12953-017-0122-4 · Cited by 163
Self-citationRecent advances in identifying protein targets in drug discovery
Ha, J., Park, H., Park, J., & Park, S. B. (2020) · Cell chemical biology · doi:10.1016/j.chembiol.2020.12.001 · Cited by 161
Dziekan, J. M., Wirjanata, G., Dai, L., Go, K. D., Yu, H., Lim, Y. T., Chen, L., Wang, L. C., Puspita, B., Prabhu, N., et al. (2020) · Nature Protocols · doi:10.1038/s41596-020-0310-z · Cited by 129
Chemoproteomics and Chemical Probes for Target Discovery
Drewes, G., & Knapp, S. (2018) · Trends in Biotechnology · doi:10.1016/j.tibtech.2018.06.008 · Cited by 132
Sun, C., Zhou, J., Yu, Z., Huo, X., Zhang, J., Morisseau, C. H. P., Hammock, B. D., & Ma, X. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2118818119 · Cited by 134
Dai, L., Prabhu, N., Yu, L. Y., Bacanu, S., Ramos, A. D., & Nordlund, P. (2019) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-062917-012837 · Cited by 128
Quantitative Proteomics Using Isobaric Labeling: A Practical Guide
Chen, X., Sun, Y., Zhang, T., Shu, L., Roepstorff, P., & Yang, F. (2021) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2021.08.012 · Cited by 133
The functional proteome landscape of Escherichia coli
Mateus, A., Hevler, J. F., Bobonis, J., Kurzawa, N., Shah, M., Mitosch, K., Goemans, C., Helm, D., Stein, F., Typas, A., et al. (2020) · Nature · doi:10.1038/s41586-020-3002-5 · Cited by 113
Self-citationSolvent-Induced Protein Precipitation for Drug Target Discovery on the Proteomic Scale
Zhang, X., Wang, Q., Li, Y., Ruan, C., Wang, S., Hu, L., & Ye, M. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b04531 · Cited by 119
Target deconvolution of HDAC pharmacopoeia reveals MBLAC2 as common off-target
Lechner, S., Malgapo, M. I. P., Grätz, C., Steimbach, R. R., Baron, A., Rüther, P. L., Nadal, S., Stumpf, C., Loos, C., Ku, X., et al. (2022) · Nature Chemical Biology · doi:10.1038/s41589-022-01015-5 · Cited by 121
Prediction of intracellular exposure bridges the gap between target- and cell-based drug discovery
Mateus, A., Gordon, L. J., Wayne, G. J., Almqvist, H., Axelsson, H., Seashore-Ludlow, B. A., Treyer, A., Matsson, P., Lundbäck, T., West, A., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1701848114 · Cited by 106
Nonparametric Analysis of Thermal Proteome Profiles Reveals Novel Drug-binding Proteins*
Childs, D., Bach, K., Franken, H., Anders, S., Kurzawa, N., Bantscheff, M., Savitski, M. M., & Huber, W. K. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.tir119.001481 · Cited by 103
Self-citationMiettinen, T. P., Peltier, J., Härtlová, A., Gierliński, M., Jansen, V. M., Trost, M., & Björklund, M. (2018) · The EMBO Journal · doi:10.15252/embj.201798359 · Cited by 106
Photoaffinity labelling strategies for mapping the small molecule–protein interactome
Burton, N. R., Kim, P., & Backus, K. M. (2021) · Organic & Biomolecular Chemistry · doi:10.1039/d1ob01353j · Cited by 106
An overview of kinase downregulators and recent advances in discovery approaches
Wang, B., Wu, H., Hu, C., Wang, H., Liu, J., Wang, W., & Liu, Q. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00826-7 · Cited by 93
Plant Chemical Genetics: From Phenotype-Based Screens to Synthetic Biology
Dejonghe, W., & Russinova, E. (2017) · PLANT PHYSIOLOGY · doi:10.1104/pp.16.01805 · Cited by 87
Recent advances in isobaric labeling and applications in quantitative proteomics
Sivanich, M. K., Gu, T., Tabang, D. N., & Li, L. (2022) · PROTEOMICS · doi:10.1002/pmic.202100256 · Cited by 79
Systematic analysis of drug combinations against Gram-positive bacteria
Cacace, E., Kim, V., Varik, V., Knopp, M. R., Tietgen, M., Brauer-Nikonow, A., İnecik, K., Mateus, A., Milanese, A., Mårli, M. T., et al. (2023) · Nature Microbiology · doi:10.1038/s41564-023-01486-9 · Cited by 77
Self-citationImportance of Quantifying Drug-Target Engagement in Cells
Stefaniak, J., & Huber, K. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00570 · Cited by 78
A Probe for NLRP3 Inflammasome Inhibitor MCC950 Identifies Carbonic Anhydrase 2 as a Novel Target
Kennedy, C. R., Goya Grocin, A., Kovačič, T., Singh, R., Ward, J. A., Shenoy, A. R., & Tate, E. W. (2021) · ACS Chemical Biology · doi:10.1021/acschembio.1c00218 · Cited by 81
Kaur, U., He, M., Lui, F., Ma, R., Ogburn, R. N., Johnson, J. H. R., Fitzgerald, M. C., & Jones, L. M. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00341 · Cited by 77
Lee, P. Y., Yeoh, Y., & Low, T. Y. (2022) · FEBS Journal · doi:10.1111/febs.16442 · Cited by 79
Quantifying Target Occupancy of Small Molecules Within Living Cells
Robers, M. B., Ohana, R. F., Huber, K., Kilpatrick, L. E., Vasta, J. D., Berger, B., Chaudhry, C., Hill, S. J., Müller, S., Knapp, S., et al. (2020) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-011420-092302 · Cited by 74
Drug Target Identification in Tissues by Thermal Proteome Profiling
Mateus, A., Kurzawa, N., Perrin, J., Bergamini, G., & Savitski, M. M. (2021) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-052120-013205 · Cited by 71
Self-citationHuman gut bacteria bioaccumulate per- and polyfluoroalkyl substances
Lindell, A. E., Grießhammer, A., Michaelis, L., Papagiannidis, D., Ochner, H., Kamrad, S., Guan, R., Blasche, S., Ventimiglia, L. N., Ramachandran, B., et al. (2025) · Nature Microbiology · doi:10.1038/s41564-025-02032-5 · Cited by 72
Self-citationComess, K. M., McLoughlin, S. M., Oyer, J. A., Richardson, P. L., Stöckmann, H., Vasudevan, A., & Warder, S. E. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01921 · Cited by 66
Friman, T. (2019) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.115174 · Cited by 66
Proteomic approaches advancing targeted protein degradation
Sathe, G. J., & Sapkota, G. P. (2023) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2023.08.007 · Cited by 68
CETSA in integrated proteomics studies of cellular processes
Prabhu, N., Dai, L., & Nordlund, P. (2019) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2019.11.004 · Cited by 59
Legler, J., Zalko, D., Jourdan, F., Jacobs, M. N., Fromenty, B., Balaguer, P., Bourguet, W., Kos, V. M., Nadal, Á., Beausoleil, C., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103480 · Cited by 55
Kurzawa, N., Becher, I., Sridharan, S., Franken, H., Mateus, A., Anders, S., Bantscheff, M., Huber, W., & Savitski, M. M. (2020) · Nature Communications · doi:10.1038/s41467-020-19529-8 · Cited by 53
Self-citationProteomics in the pharmaceutical and biotechnology industry: a look to the next decade
Lill, J. R., Mathews, W. R., Rose, C. M., & Schirle, M. (2021) · Expert Review of Proteomics · doi:10.1080/14789450.2021.1962300 · Cited by 57
High-throughput functional characterization of protein phosphorylation sites in yeast
Viéitez, C., Busby, B. P., Ochoa, D., Mateus, A., Memon, D., Galardini, M., Yildiz, U., Trovato, M., Jawed, A., Geiger, A. G., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-021-01051-x · Cited by 60
Self-citationChemoproteomics, A Broad Avenue to Target Deconvolution
Gao, Y., Ma, M., Li, W., & Lei, X. (2023) · Advanced Science · doi:10.1002/advs.202305608 · Cited by 54
The tissue proteome in the multi-omic landscape of kidney disease
Rinschen, M. M., & Sáez-Rodríguez, J. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-00348-5 · Cited by 56
Lim, Y. T., Prabhu, N., Dai, L., Go, K. D., Chen, D., Sreekumar, L., Egeblad, L., Eriksson, S., Chen, L., Veerappan, S., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0208273 · Cited by 52
Ibrahim, H. S., Abdelsalam, M., Zeyn, Y., Zessin, M., Mustafa, A.-H. M., Fischer, M. A., Zeyen, P., Sun, P., Bülbül, E. F., Vecchio, A., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010369 · Cited by 50
Improved Proteomics-Based Drug Mechanism-of-Action Studies Using 16-Plex Isobaric Mass Tags
Zinn, N., Werner, T., Doce, C., Mathieson, T., Boecker, C., Sweetman, G., Fufezan, C., & Bantscheff, M. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00900 · Cited by 49
Self-citationZhang, X., Wang, K., Wu, S., Ruan, C., Li, K., Wang, Y., Zhu, H., Liu, X., Liu, Z., Li, G., et al. (2022) · Chemical Science · doi:10.1039/d2sc03326g · Cited by 45
Perspective on CETSA Literature: Toward More Quantitative Data Interpretation
Seashore-Ludlow, B. A., Axelsson, H., & Lundbäck, T. (2019) · SLAS DISCOVERY · doi:10.1177/2472555219884524 · Cited by 45
Beusch, C. M., Sabatier, P., & Zubarev, R. A. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c00391 · Cited by 47
Selkrig, J., Li, N., Hausmann, A., Mangan, M., Zietek, M., Mateus, A., Bobonis, J., Sueki, A., Imamura, H., Debs, B. E., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0736-7 · Cited by 46
Self-citationMatrix Thermal Shift Assay for Fast Construction of Multidimensional Ligand–Target Space
Ruan, C., Wang, Y., Zhang, X., Lyu, J., Zhang, N., Ma, Y., Shi, C., Qu, G., & Ye, M. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.1c04627 · Cited by 40
Choi, S. A., Lee, C., Kwak, P. A., Park, C., Wang, K., Phi, J. H., Lee, J. Y., Chong, S., & Kim, S. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.10.012 · Cited by 40
Modification-free approaches to screen drug targets at proteome level
Lyu, J., Wang, K., & Ye, M. (2019) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2019.06.024 · Cited by 40
Discovery of metal-binding proteins by thermal proteome profiling
Zeng, X., Wei, T., Wang, X., Liu, Y., Tan, Z., Zhang, Y., Tianyu, F., Cheng, Y., Wang, F., Ma, B., et al. (2024) · Nature Chemical Biology · doi:10.1038/s41589-024-01563-y · Cited by 40
Chemical genetics in drug discovery
Cacace, E., Kritikos, G., & Typas, A. (2017) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2017.05.020 · Cited by 38
Label-free target identification in drug discovery via phenotypic screening
Park, H., Ha, J., & Park, S. B. (2019) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2019.02.006 · Cited by 40
Posttranslational Modifications Drive Protein Stability to Control the Dynamic Beer Brewing Proteome
Kerr, E. D., Caboche, C. H., & Schulz, B. L. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra119.001526 · Cited by 40
Aggregation and disaggregation features of the human proteome
Määttä, T. A., Rettel, M., Sridharan, S., Helm, D., Kurzawa, N., Stein, F., & Savitski, M. M. (2020) · Molecular Systems Biology · doi:10.15252/msb.20209500 · Cited by 34
Self-citationThermal proteome profiling: Insights into protein modifications, associations, and functions.
Sueur, C. L., Hammarén, H. M., Sridharan, S., & Savitski, M. (2022) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2022.102225 · Cited by 31
Self-citationTampere, M., Pettke, A., Salata, C., Wallner, O. A., Koolmeister, T., Cázares‐Körner, A., Visnes, T., Hesselman, M. C., Kunold, E., Wiita, E., et al. (2020) · Viruses · doi:10.3390/v12121423 · Cited by 39
SARS‐CoV‐2 infection remodels the host protein thermal stability landscape
Selkrig, J., Stanifer, M. L., Mateus, A., Mitosch, K., Barrio‐Hernandez, I., Rettel, M., Kim, H., Voogdt, C. G. P., Walch, P., Kee, C., et al. (2021) · Molecular Systems Biology · doi:10.15252/msb.202010188 · Cited by 38
Self-citationPhotoaffinity Labeling Chemistries Used to Map Biomolecular Interactions
West, A. V., & Woo, C. M. (2022) · Israel Journal of Chemistry · doi:10.1002/ijch.202200081 · Cited by 42
Ruan, C., Ning, W., Liu, Z., Zhang, X., Fang, Z., Li, Y., Dang, Y., Xue, Y., & Ye, M. (2022) · ACS Chemical Biology · doi:10.1021/acschembio.1c00936 · Cited by 34
Cabrera, A., Wiebelhaus, N., Quan, B., Ma, R., He, M., & Fitzgerald, M. C. (2019) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.9b00041 · Cited by 34
Progress and pitfalls of using isobaric mass tags for proteome profiling
Dayon, L., & Affolter, M. (2020) · Expert Review of Proteomics · doi:10.1080/14789450.2020.1731309 · Cited by 34
Recent advances in proteome‐wide label‐free target deconvolution for bioactive small molecules
Sun, J., Prabhu, N., Tang, J., Yang, F., Jia, L., Guo, J., Xiao, K., Tam, W. L., Nordlund, P., & Dai, L. (2021) · Medicinal Research Reviews · doi:10.1002/med.21788 · Cited by 35
Epigenetic assays for chemical biology and drug discovery
Gul, S. (2017) · Clinical Epigenetics · doi:10.1186/s13148-017-0342-6 · Cited by 31
In situ analysis reveals the TRiC duty cycle and PDCD5 as an open-state cofactor
Xing, H., Rosenkranz, R. R. E., Rodriguez-Aliaga, P., Lee, T.-T., Majtner, T., Böhm, S., Turoňová, B., Frydman, J., & Beck, M. (2024) · Nature · doi:10.1038/s41586-024-08321-z · Cited by 30
High-throughput drug target discovery using a fully automated proteomics sample preparation platform
Wu, Q. D., Zheng, J., Sui, X., Fu, C., Cui, X., Liao, B. Y., Ji, H., Luo, Y., He, A., Lu, X. M., et al. (2024) · Chemical Science · doi:10.1039/d3sc05937e · Cited by 29
Xu, T., Chen, L., Lim, Y. T., Zhao, H., Chen, H., Chen, M., Huan, T., Huang, Y., Sobota, R. M., & Fang, M. (2021) · Environmental Science & Technology · doi:10.1021/acs.est.0c05832 · Cited by 30
Feng, F., Zhang, W., Chai, Y., Guo, D., & Chen, X. (2022) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2022.115107 · Cited by 31
Park, H., & Park, S. B. (2019) · Chemical Science · doi:10.1039/c8sc05465g · Cited by 27
Isocotoin suppresses hepatitis E virus replication through inhibition of heat shock protein 90
Nimgaonkar, I., Archer, N. F., Becher, I., Shahrad, M., LeDesma, R. A., Mateus, A., Caballero‐Gómez, J., Berneshawi, A. R., Ding, Q., Douam, F., et al. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2020.104997 · Cited by 28
Self-citationPeck Justice, S. A., Barron, M. P., Qi, G. D., Wijeratne, H. R. S., Victorino, J. F., Simpson, E. R., Vilseck, J. Z., Wijeratne, A. B., & Mosley, A. L. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.014576 · Cited by 28
Peck Justice, S. A., Qi, G., Wijeratne, H. R. S., Victorino, J. F., Simpson, E. R., Wijeratne, A. B., & Mosley, A. L. (2019) · doi:10.1101/2019.12.30.891267 · Cited by 28
In Situ Target Engagement Studies in Adherent Cells
Axelsson, H., Almqvist, H., Otrocka, M., Vallin, M., Lundqvist, S., Hansson, P., Karlsson, U., Lundbäck, T., & Seashore-Ludlow, B. A. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.7b01079 · Cited by 27
Current and emerging target identification methods for novel antimalarials
Challis, M. P., Devine, S. M., & Creek, D. J. (2022) · International Journal for Parasitology Drugs and Drug Resistance · doi:10.1016/j.ijpddr.2022.11.001 · Cited by 27
Chemical proteomics accelerates the target discovery of natural products
He, S., Li, J., Zhou, J.-C., Yang, Z., Liu, X., & Ge, Y. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116609 · Cited by 25
Friman, T., Chernobrovkin, A. L., Molina, D. M., & Arnold, L. H. (2020) · SLAS DISCOVERY · doi:10.1177/2472555220973597 · Cited by 25
Dynamic regulators of ferroptosis: Post-translational modifications in ferroptotic cell death
Yan, Y.-X., Zhou, H., Shang, X.-G., Xu, P., Tang, X., Zheng, X., Yu, L., Li, C.-T., Xie, T., & Lou, J.-S. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107815 · Cited by 24
Seashore-Ludlow, B. A., Axelsson, H., Almqvist, H., Dahlgren, B., Jönsson, M., & Lundbäck, T. (2018) · Biochemistry · doi:10.1021/acs.biochem.8b01057 · Cited by 24
A Comparison of Two Stability Proteomics Methods for Drug Target Identification in OnePot 2D Format
Xu, Y., West, G. M., Abdelmessih, M., Troutman, M. D., & Everley, R. A. (2021) · ACS Chemical Biology · doi:10.1021/acschembio.1c00317 · Cited by 24
Al-Amin, R. A., Gallant, C. J., Muthelo, P. M., & Landegren, U. D. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c02225 · Cited by 23
Molecular profiling of sponge deflation reveals an ancient relaxant-inflammatory response
Ruperti, F., Becher, I., Stokkermans, A., Wang, L., Marschlich, N., Potel, C., Maus, E., Stein, F., Drotleff, B., Schippers, K. J., et al. (2024) · Current Biology · doi:10.1016/j.cub.2023.12.021 · Cited by 23
Self-citationStability-based approaches in chemoproteomics
George, A. L., Dueñas, M. E., Marín‐Rubio, J. L., & Trost, M. (2024) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2024.6 · Cited by 24
Exploring protein conformations with limited proteolysis coupled to mass spectrometry
Leene, C. V., Moortel, L. V., Bosscher, K. D., & Gevaert, K. (2024) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2024.11.005 · Cited by 22
Metadata
- Authors
- Becher, I., Werner, T., Doce, C., Zaal, E. A., Tögel, I., Khan, C. A., Rueger, A., Muelbaier, M., Salzer, E., Berkers, C. R., Fitzpatrick, P. F., Bantscheff, M., & Savitski, M. M.
- Affiliations
- European Molecular Biology Laboratory (DE)
- Utrecht University (NL)
- The University of Texas at San Antonio Health Science Center (US)
- Corresponding author
- Bantscheff, Marcus
- Savitski, Mikhail M
- ORCID
- Venue
- Nature Chemical Biology
- Published
- 2016-09-26
- Volume
- 12
- Issue
- 11
- Pages
- 908-910
- ISSN
- 1552-4450 (ISSN-L)
- 1552-4469
- OpenAlex
- W2524972396
- Cited by
- 251
- References
- 30
- Citations by year
- 2026: 19 · 2025: 21 · 2024: 33 · 2023: 30 · 2022: 25 · 2021: 29 · 2020: 41 · 2019: 27 · 2018: 20 · 2017: 5 · 2016: 1
- FWCI
- 8.80
- Type
- journal article
- Language
- en
- Open access
- green
- dspace.library.uu.nl
- Licence
- other-oa
- www.springer.com/tdm (tdm)
- Locations
- Nature Chemical Biology (publishedVersion)
- PubMed (publishedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Utrecht University Repository (Utrecht University) (submittedVersion)
- Topics
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Keywords
- phenylalanine hydroxylase, panobinostat, off-target effects, histone deacetylase inhibitors, thermal proteome profiling, chemoproteomics, thermal shift assay, tyrosinemia, drug repurposing, phenylalanine metabolism
- MeSH terms
- Panobinostat, Dose-Response Relationship, Drug, Humans, Hydroxamic Acids, Indoles, Phenylalanine Hydroxylase, Structure-Activity Relationship, Temperature, Molecular Structure, Histone Deacetylase Inhibitors, Hep G2 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
